Novartis presents first-of-its-kind algorithm

May 7, 2019

Novartis today announced results from a validation study of the innovative, algorithm-based digital solution MS Progression Discussion Tool, or MSProDiscussTM. The tool aims to support and facilitate a discussion between physicians and patients living with multiple sclerosis (MS) who have transitioned, or are at risk of transitioning from relapsing remitting MS (RRMS) to secondary progressive MS (SPMS). Diagnosing SPMS can be challenging but if carried out in a timely manner, could help to prevent further irreversible damage3 . The study findings, presented today at the 2019 American Academy of Neurology Annual Meeting (AAN) in Philadelphia, Pennsylvania, USA, support the validity and potential use of MSProDiscuss™ to help evaluate and discuss early signs suggestive of progression in clinical practice.

Spotlight

Stichting Prisma

Providing good, modern care for people with a permanent disability. At all stages of life, throughout Brabant. That is the basis of Prisma. We have the knowledge and expertise to provide responsible care; that is what our clients count on. We also have a solid relationship with our environment. We are driven by our involvement in the ups and downs of clients and colleagues and dare to tackle matters. This way we strengthen the strengths and talents of clients and employees. We want our clients to feel that they make a difference: they give direction to our work. By standing shoulder to shoulder with our clients, we contribute to a valuable life. A life about which the client himself directs.

Other Infographics
news image

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Read More
news image

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

Pharmaceutical industry and medicine

Infographic | March 12, 2022

Pharmaceutical industry and medicine vector infographics with drugs, pills, bottles and packages, text blocks and charts all around

Read More
news image

What Does The Pharma IndustryWant From CROs?

Infographic | June 16, 2022

Use Informa Pharma Intelligence’s marketing and pharma expertise to conduct industry research, produce engaging thought leadership content,

Read More
news image

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.

Read More

Spotlight

Stichting Prisma

Providing good, modern care for people with a permanent disability. At all stages of life, throughout Brabant. That is the basis of Prisma. We have the knowledge and expertise to provide responsible care; that is what our clients count on. We also have a solid relationship with our environment. We are driven by our involvement in the ups and downs of clients and colleagues and dare to tackle matters. This way we strengthen the strengths and talents of clients and employees. We want our clients to feel that they make a difference: they give direction to our work. By standing shoulder to shoulder with our clients, we contribute to a valuable life. A life about which the client himself directs.

Events